A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism

J. H Duncan Bassett, Allan J. Williams, Elaine Murphy, Alan Boyde, Peter G T Howell, Rowan Swinhoe, Marta Archanco, Frédéric Flamant, Jacques Samarut, Sabine Costagliola, Gilbert Vassart, Roy E Weiss, Samuel Refetoff, Graham R. Williams

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

By proposing TSH as a key negative regulator of bone turnover, recent studies in TSH receptor (TSHR) null mice challenged the established view that skeletal responses to disruption of the hypothalamic-pituitarythyroid axis result from altered thyroid hormone (T3) action in bone. Importantly, this hypothesis does not explain the increased risk of osteoporosis in Graves' disease patients, in which circulating TSHR-stimulating antibodies are pathognomonic. To determine the relative importance of T3 and TSH in bone, we compared the skeletal phenotypes of two mouse models of congenital hypothyroidism in which the normal reciprocal relationship between thyroid hormones and TSH was intact or disrupted. Pax8 null (Pax8-/-) mice have a 1900-fold increase in TSH and a normal TSHR, whereas hyt/hyt mice have a 2300-fold elevation of TSH but a nonfunctional TSHR. We reasoned these mice must display opposing skeletal phenotypes if TSH has a major role in bone, whereas they would be similar if thyroid hormone actions predominate. Pax8-/- and hyt/hyt mice both displayed delayed ossification, reduced cortical bone, a trabecular bone remodeling defect, and reduced bone mineralization, thus indicating that the skeletal abnormalities of congenital hypothyroidism are independent of TSH. Treatment of primary osteoblasts and osteoclasts with TSH or a TSHR-stimulating antibody failed to induce a cAMP response. Furthermore, TSH did not affect the differentiation or function of osteoblasts or osteoclasts in vitro. These data indicate the hypothalamic-pituitary-thyroid axis regulates skeletal development via the actions of T3.

Original languageEnglish (US)
Pages (from-to)501-512
Number of pages12
JournalMolecular Endocrinology
Volume22
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Thyrotropin
Hypothyroidism
Thyroid Hormones
Thyrotropin Receptors
Congenital Hypothyroidism
Bone Remodeling
Osteoclasts
Osteoblasts
Bone and Bones
Phenotype
Physiologic Calcification
Graves Disease
Triiodothyronine
Osteogenesis
Osteoporosis
Thyroid Gland

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Bassett, J. H. D., Williams, A. J., Murphy, E., Boyde, A., Howell, P. G. T., Swinhoe, R., ... Williams, G. R. (2008). A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Molecular Endocrinology, 22(2), 501-512. https://doi.org/10.1210/me.2007-0221

A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. / Bassett, J. H Duncan; Williams, Allan J.; Murphy, Elaine; Boyde, Alan; Howell, Peter G T; Swinhoe, Rowan; Archanco, Marta; Flamant, Frédéric; Samarut, Jacques; Costagliola, Sabine; Vassart, Gilbert; Weiss, Roy E; Refetoff, Samuel; Williams, Graham R.

In: Molecular Endocrinology, Vol. 22, No. 2, 02.2008, p. 501-512.

Research output: Contribution to journalArticle

Bassett, JHD, Williams, AJ, Murphy, E, Boyde, A, Howell, PGT, Swinhoe, R, Archanco, M, Flamant, F, Samarut, J, Costagliola, S, Vassart, G, Weiss, RE, Refetoff, S & Williams, GR 2008, 'A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism', Molecular Endocrinology, vol. 22, no. 2, pp. 501-512. https://doi.org/10.1210/me.2007-0221
Bassett, J. H Duncan ; Williams, Allan J. ; Murphy, Elaine ; Boyde, Alan ; Howell, Peter G T ; Swinhoe, Rowan ; Archanco, Marta ; Flamant, Frédéric ; Samarut, Jacques ; Costagliola, Sabine ; Vassart, Gilbert ; Weiss, Roy E ; Refetoff, Samuel ; Williams, Graham R. / A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. In: Molecular Endocrinology. 2008 ; Vol. 22, No. 2. pp. 501-512.
@article{80ce354e22a346e5813acffdc27e559d,
title = "A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism",
abstract = "By proposing TSH as a key negative regulator of bone turnover, recent studies in TSH receptor (TSHR) null mice challenged the established view that skeletal responses to disruption of the hypothalamic-pituitarythyroid axis result from altered thyroid hormone (T3) action in bone. Importantly, this hypothesis does not explain the increased risk of osteoporosis in Graves' disease patients, in which circulating TSHR-stimulating antibodies are pathognomonic. To determine the relative importance of T3 and TSH in bone, we compared the skeletal phenotypes of two mouse models of congenital hypothyroidism in which the normal reciprocal relationship between thyroid hormones and TSH was intact or disrupted. Pax8 null (Pax8-/-) mice have a 1900-fold increase in TSH and a normal TSHR, whereas hyt/hyt mice have a 2300-fold elevation of TSH but a nonfunctional TSHR. We reasoned these mice must display opposing skeletal phenotypes if TSH has a major role in bone, whereas they would be similar if thyroid hormone actions predominate. Pax8-/- and hyt/hyt mice both displayed delayed ossification, reduced cortical bone, a trabecular bone remodeling defect, and reduced bone mineralization, thus indicating that the skeletal abnormalities of congenital hypothyroidism are independent of TSH. Treatment of primary osteoblasts and osteoclasts with TSH or a TSHR-stimulating antibody failed to induce a cAMP response. Furthermore, TSH did not affect the differentiation or function of osteoblasts or osteoclasts in vitro. These data indicate the hypothalamic-pituitary-thyroid axis regulates skeletal development via the actions of T3.",
author = "Bassett, {J. H Duncan} and Williams, {Allan J.} and Elaine Murphy and Alan Boyde and Howell, {Peter G T} and Rowan Swinhoe and Marta Archanco and Fr{\'e}d{\'e}ric Flamant and Jacques Samarut and Sabine Costagliola and Gilbert Vassart and Weiss, {Roy E} and Samuel Refetoff and Williams, {Graham R.}",
year = "2008",
month = "2",
doi = "10.1210/me.2007-0221",
language = "English (US)",
volume = "22",
pages = "501--512",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism

AU - Bassett, J. H Duncan

AU - Williams, Allan J.

AU - Murphy, Elaine

AU - Boyde, Alan

AU - Howell, Peter G T

AU - Swinhoe, Rowan

AU - Archanco, Marta

AU - Flamant, Frédéric

AU - Samarut, Jacques

AU - Costagliola, Sabine

AU - Vassart, Gilbert

AU - Weiss, Roy E

AU - Refetoff, Samuel

AU - Williams, Graham R.

PY - 2008/2

Y1 - 2008/2

N2 - By proposing TSH as a key negative regulator of bone turnover, recent studies in TSH receptor (TSHR) null mice challenged the established view that skeletal responses to disruption of the hypothalamic-pituitarythyroid axis result from altered thyroid hormone (T3) action in bone. Importantly, this hypothesis does not explain the increased risk of osteoporosis in Graves' disease patients, in which circulating TSHR-stimulating antibodies are pathognomonic. To determine the relative importance of T3 and TSH in bone, we compared the skeletal phenotypes of two mouse models of congenital hypothyroidism in which the normal reciprocal relationship between thyroid hormones and TSH was intact or disrupted. Pax8 null (Pax8-/-) mice have a 1900-fold increase in TSH and a normal TSHR, whereas hyt/hyt mice have a 2300-fold elevation of TSH but a nonfunctional TSHR. We reasoned these mice must display opposing skeletal phenotypes if TSH has a major role in bone, whereas they would be similar if thyroid hormone actions predominate. Pax8-/- and hyt/hyt mice both displayed delayed ossification, reduced cortical bone, a trabecular bone remodeling defect, and reduced bone mineralization, thus indicating that the skeletal abnormalities of congenital hypothyroidism are independent of TSH. Treatment of primary osteoblasts and osteoclasts with TSH or a TSHR-stimulating antibody failed to induce a cAMP response. Furthermore, TSH did not affect the differentiation or function of osteoblasts or osteoclasts in vitro. These data indicate the hypothalamic-pituitary-thyroid axis regulates skeletal development via the actions of T3.

AB - By proposing TSH as a key negative regulator of bone turnover, recent studies in TSH receptor (TSHR) null mice challenged the established view that skeletal responses to disruption of the hypothalamic-pituitarythyroid axis result from altered thyroid hormone (T3) action in bone. Importantly, this hypothesis does not explain the increased risk of osteoporosis in Graves' disease patients, in which circulating TSHR-stimulating antibodies are pathognomonic. To determine the relative importance of T3 and TSH in bone, we compared the skeletal phenotypes of two mouse models of congenital hypothyroidism in which the normal reciprocal relationship between thyroid hormones and TSH was intact or disrupted. Pax8 null (Pax8-/-) mice have a 1900-fold increase in TSH and a normal TSHR, whereas hyt/hyt mice have a 2300-fold elevation of TSH but a nonfunctional TSHR. We reasoned these mice must display opposing skeletal phenotypes if TSH has a major role in bone, whereas they would be similar if thyroid hormone actions predominate. Pax8-/- and hyt/hyt mice both displayed delayed ossification, reduced cortical bone, a trabecular bone remodeling defect, and reduced bone mineralization, thus indicating that the skeletal abnormalities of congenital hypothyroidism are independent of TSH. Treatment of primary osteoblasts and osteoclasts with TSH or a TSHR-stimulating antibody failed to induce a cAMP response. Furthermore, TSH did not affect the differentiation or function of osteoblasts or osteoclasts in vitro. These data indicate the hypothalamic-pituitary-thyroid axis regulates skeletal development via the actions of T3.

UR - http://www.scopus.com/inward/record.url?scp=38749088288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749088288&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0221

DO - 10.1210/me.2007-0221

M3 - Article

VL - 22

SP - 501

EP - 512

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 2

ER -